Baylor Scott & White Center for Inflammatory Bowel Diseases

Llamar al horario

Seguros aceptados

Baylor Scott & White ha establecido acuerdos con varios tipos de seguros para garantizar que sus necesidades de salud estén cubiertas.

Plan de seguro o compañía

Al buscar aceptas estos términos

Etna - (2)

Planes de Medicare Advantage

Administradores de firmas de Aetna
Blue Cross Blue Shield - (9)

Ventaja azul hmo

Opción azul ppo

Premier Azul

HMO de acceso abierto Blue Premier

Ventaja de Medicare - Oncor

Parplan

TRADICIONAL

Indemnidad

Esenciales azules
Cigna - (4)

Plan para empleados del Children's Medical Center

Plan de empleados de la Ciudad de Dallas

Localplus

Acceso abierto plus
DFW ConnectedCare - (1)

Plan de beneficios para empleados de American Airlines
Healthscope- (2)

DARDO ACO Flex

Dardo aco flex plus
HealthSmart - (2)

Red ACCEL

Red preferida
Humana - (4)

Cuidado de la elección

Preferido por Humana

TPV Nacional

Planes Comerciales PPO
Parkland Community Health - (2)

CHIPMedicaid

Medicaid de Healthfirst
Plan de salud Scott & White - (16)

Red HMO - Individual / Familiar

Red EPO - Individual / Familia

2019 Red de empleados de BSWH - PPO y HSA

2019 Red de empleados de BSWH - SEQA & EQA

Seniorcare advantage hmo

Seniorcare advantage ppo

Red HMO - Grupo

TRS - Red de participantes de Active Care

Red PPO - Grupo

Red de elección ppo

Ppo elección red preferida

Red Cigna PPO - Plan para miembros fuera del área

Estado de Texas PPO

PHCS / ARGUS - Red PPO - Plan de miembros fuera del área

Red EPO - Grupo

Red del grupo McLane
Superior Health Plan - (1)

ESTRELLA+MÁS
Superior Health Plan - (3)

Plan de necesidades duales de Medicare/Medicaid: Advantage HMO SNP

Plan Medicare/Medicaid

ESTRELLA+MÁS
United Health - (2)

Nexo aco oa

Nexusaco r
University Mary Hardin-Baylor - (1)

Plan de beneficios para empleados

Servicios médicos

Baylor Scott & White Center for Inflammatory Bowel Diseases offers expertise and IDB treatment options conveniently located near you.

Enfermedad de Crohn

Crohn's disease is an inflammatory bowel disease (IBD) in which chronic inflammation causes damage to the gastrointestinal tract, typically the small intestine and/or the colon. There is no medical or surgical cure for Crohn's disease at the present time.

Learn more about Crohn's disease

Enfermedades del Aparato digestivo

We specialize in the diagnosis and treatment of inflammatory bowel disease, including Crohn's disease and ulcerative colitis.

We perform a variety of procedures to diagnosis and monitor the digestive tract:

Capsule study
Chromoendoscopy
Colonoscopia
Enteroscopy
Ileoscopy
Pouchoscopy
Sigmoidoscopy
Upper endoscopy (EGD)

In addition, we offer infusion therapies to manage symptoms:

Ulcerative colitis

Ulcerative colitis is an inflammatory bowel disease (IBD) in which inflammation causes damage to the large intestine—the colon and rectum. It is a chronic disease without medical cure at the present time.

Learn more about ulcerative colitis

Pagar la factura

Baylor Scott & White Health se complace en ofrecerle múltiples opciones para pagar su factura. Vea nuestra guía para comprender su estado de cuenta de Baylor Scott & White.

Ofrecemos dos opciones de pago en línea:

Realiza un pago único sin registrarte seleccionando el Opción "Pagar una factura como invitado".
Inscríbete o inicie sesión en su cuenta MyBSWHealth para ver los estados de cuenta y los estados de cuenta, configurar un plan de pago o inscribirse en estados de cuenta electrónicos.

Otras opciones de pago:

Pago por correo

Para asegurarse de que su pago se aplique correctamente a su cuenta, separe el comprobante de su estado de cuenta de Baylor Scott & White y devuelva el comprobante con su pago. Si paga con cheque o giro postal, asegúrese de incluir su número de cuenta en el cheque o giro postal.

Envíe el pago por correo a la dirección que figura en su estado de cuenta.
Pagar por teléfono

Los pagos a HTPN se pueden realizar por teléfono con nuestro sistema de pago telefónico automatizado 24 horas al día, los siete días de la semana. Todos los pagos realizados a través del sistema de pago telefónico automatizado se publicarán el siguiente día hábil. Por favor llama 1.866.377.1650.

Si necesita hablar con alguien sobre una factura de un Hospital Baylor Scott & White, nuestro departamento de Atención al Cliente está disponible para recibir pagos por teléfono de lunes a viernes de 8:00 AM a 5:00 PM y puede comunicarse con usted al 1.800.994.0371.
Pagar en persona

Los pagos se pueden hacer en persona en el centro donde recibió los servicios.

Asistencia financiera

En Baylor Scott & White Health, queremos ser un recurso para usted y su familia. Nuestro equipo de representantes de servicio al cliente y asesores financieros están aquí para ayudarlo a encontrar soluciones financieras que puedan ayudar a cubrir el costo de su atención. Le recomendamos que hable con un miembro de nuestro equipo en cualquier momento antes, durante o después de recibir la atención.

Ver opciones de asistencia financiera

El móvil lo hace fácil

Al igual que facilitamos la atención cuando su hijo está enfermo o lesionado, nuestra aplicación mejor calificada, MyBSWHealth, puede simplificar el mantenimiento de su salud. La aplicación le permite programar citas, enviar mensajes a su pediatra, ver los registros médicos de su hijo y programar atención virtual el mismo día desde su computadora, teléfono inteligente o tableta.

Texto MEJOR a 88408

Formularios para pacientes

If you are a new patient, you must fill out the release of information to HTPN, assessment, and registration completely. You can either fax or email your forms to the clinic. This helps reduce delays at your appointment time.

Registro

You may bring these to your appointment.

Release of information

We need this form as soon as possible in order to request your medical records from other providers involved in your care. If our office does not receive this form in a timely manner, then our office will be unable to obtain medical records relating to your condition. In order for your appointment to run smoothly and in a timely manner we require having medical records prior to appointment. If we do not receive your release of information in a timely manner we will, unfortunately, have to reschedule your appointment.

Assessment

The assessment is detailed, but it is so we can provide the best care to you. Please take your time filling this form out, and give us as much detail as you need to. Themistocles Dassopoulos, MD, requires that the health assessment is done prior to you coming in for your appointment. Dr. Dassopoulos will evaluate your history and present-day symptoms to prepare for your upcoming visit.

Health history form

Otro

Patient education and resources

Procedure prep

Where to go for procedures

GI/Endoscopy Lab
Truett Hospital, First Floor
Baylor University Medical Center Campus

3501 Junius St
Dallas, TX 75246

News and media

Crohn's Disease Life Expectancy
Dr. Dassopoulos was recently interviewed by US News and World Report on the topic of mortality of Crohn's disease. Dr. Dassopoulos emphasized that the life span of individuals suffering from Crohn's disease is essentially the same as that of the general population.
Read article

IBS and IBD: More Than Just Tummy Trouble
Listen to Dr. Dassopoulos on KERA, Vital Signs series, explain the differences between IBS and IBD.
Read article

Ask the Expert: Irritable Bowel Syndrome and Inflammatory Bowel Disease (Part 1)
Dr Dassopoulos discusses the differences between Irritable Bowel Syndrome (IBS) and Inflammatory Bowel Disease (IBD)
Watch the video

Ask the Expert: Irritable Bowel Syndrome and Inflammatory Bowel Disease (Part 2)
Dr. Dassopoulos educates on the most common symptoms, causes and therapies of IBD.
Watch the video

Medication cost assistance

Pharmaceutical companies offer patient assistance programs which provide assistance to those who need financial support in paying for their medication. Please note, these programs usually apply to those who are uninsured. To find information on various patient assistance programs providing assistance for specific medication, the links are:

Recursos educativos

BSWH patient education

Online resources

Investigación y ensayos clínicos

Baylor Scott & White Center for Inflammatory Bowel Diseases conducts a number of ongoing research studies that may benefit you, including clinical trials of medications that hold the promise of improving the health of patients with ulcerative colitis or Crohn's disease. To learn more, contact the Dallas clinical trials office at 214.818.9688.

Research overview

The Center for IBD Research performs cutting-edge, impactful translational and basic research on IBD to improve our understanding of the disease and develop better treatments.

Inflammatory bowel diseases and autophagy
Crohn’s disease of the ileum
Barrier function of the intestinal epithelium
Colitis-associated colorectal cancer
Intestinal stem cell responses to inflammation and diet

Dr. Theiss published an article on factors driving inflammation progression to cancer.

Faculty

Arianne L. Theiss, PhD, Research Director
Themistocles Dassopoulos, MD, Medical Director
Jie Han, MD, MS

Crohn's disease trials

A Phase 3, Multicenter, Randomized, Double-Blind, Placebo-and Active-Controlled, Treat-Through Study to Evaluate the Efficacy and Safety of Mirikizumab in Patients with Moderately to Severely Active Crohn's Disease

A Phase 3, Multicenter, Randomized, Efficacy Assessor-Blinded study of Risankizumab Compared to Ustekinumab for the Treatment of Adult Subjects With Moderate to Severe Crohn’s Disease who have failed anti-TNF therapy

A Multicenter, Randomized, Double-Blind, Placebo-Controlled Induction Study of the Efficacy and Safety of Risankizumab in Subjects with Moderately to Severely Active Crohn's Disease.

A Study of the Efficacy and Safety of Risankizumab in Subjects With Crohn's Disease Who Responded to Induction Treatment in M16-006 or M15-991; or Completed M15-989

A Study of the Efficacy and Safety of Upadacitinib (ABT-494) in Subjects With Moderately to Severely Active Crohn's Disease Who Have Inadequately Responded to or Are Intolerant to Conventional Therapies But Have Not Failed Biologic Therapy

A Maintenance and Long-Term Extension Study of the Efficacy and Safety of Upadacitinib (ABT-494) in Subjects With Crohn's Disease Who Completed the Studies M14-431 or M14-433

Ulcerative colitis trials

A Study to Evaluate the Safety and Efficacy of Upadacitinib (ABT-494) for Induction and Maintenance Therapy in Subjects With Moderately to Severely Active Ulcerative Colitis (UC)

A Study to Evaluate the Long-Term Safety and Efficacy of Upadacitinib (ABT-494) in Subjects With Ulcerative Colitis (UC)

A Study of the Efficacy and Safety of Upadacitinib (ABT-494) in Participants With Moderately to Severely Active Ulcerative Colitis

BI 655130 Induction Treatment in Patients With Moderate-to-severe Ulcerative Colitis

Baylor Scott & White Center for Inflammatory Bowel Diseases

Seguros aceptados